Desk
Every story stays here. Filter by topic, search older headlines, and save favorites to your member record. Educational notes only — not medical advice.
465 stories
ScienceDaily · 24 Sept 2026 · Supplements / medicine
A 70-year-old leukemia drug is still revealing new secrets. Researchers found that removing a protein called NUDT5 protected cells from the drug, even though simply blocking the protein had little effect. The unexpected result points to a hidden cellular role that could help explain why people respond differently to certain leukemia treatments.
ScienceDaily · 24 Sept 2026 · Exercise
A newly identified breakdown in communication between nerves and muscles could help explain why people lose strength as they age. Researchers were able to improve muscle strength in an animal model by targeting a key protein, raising hopes that some age-related weakness could eventually be treated.
WHO · 23 May 2024 · Research
Ahead of the Seventy-seventh World Health Assembly , the Qatar Fund for Development (QFFD) and the World Health Organization (WHO) have signed a Core Contribution Agreement to support the implementation of WHO’s extended Thirteenth General Programme of Work. The agreement entails a contribution of US$ 4 million from the State of Qatar to WHO, through QFFD, aimed at enhancing the Organization's efforts in addres
ScienceDaily · 18 Sept 2026 · Supplements / medicine
Ozempic and other GLP-1 medications can improve blood sugar, weight, and cardiovascular health, but researchers found little evidence that they also improve mental health, employment, marriage, or overall well-being. The findings suggest the drugs’ broader life effects may be subtler than their dramatic physical health benefits. Educational supplement parallel (not a replacement): When headlines discuss GLP-1 medicines and aging, people often research food-first fiber or bitter-botanical “pathway support” formulas. Those are not semaglutide, not compounded GLP-1, and not a substitute for a prescribed GLP-1 drug. Mouse or marketing claims are hype until human outcome data exist. Weakly evidenced. Store: /store/glp1-pathway-support. Not medical advice. Not a substitute for a prescribed medicine. Off-label prescription use is clinician-only. VitaLonga does not diagnose, treat, or cure disease. Never start, stop, or replace a prescription with a supplement on the basis of a headline.
ScienceDaily · 17 Sept 2026 · Supplements / medicine
A kimchi-derived bacterium can bind to nanoplastics under gut-like conditions and may help carry them out of the body. In mice, the probiotic more than doubled the amount of nanoplastics detected in feces, pointing to a surprising potential use for microbes from fermented foods.
ScienceDaily · 17 Sept 2026 · Nutrition
A natural compound produced by gut bacteria after digesting foods such as pomegranates, walnuts, and berries may help repair and protect the intestinal lining. The discovery reveals a surprising beneficial side of an inflammatory pathway and could inspire more targeted treatments for Crohn’s disease and ulcerative colitis.
ScienceDaily · 17 Sept 2026 · Research
Scientists discovered that brain-cell axons may not be smooth tubes as textbooks have shown for more than a century, but instead naturally resemble strings of tiny pearls. Those pearl-like structures can change with neural activity and may help control how quickly electrical signals travel through the brain.
ScienceDaily · 17 Sept 2026 · Supplements / medicine
Scientists are testing a counterintuitive way to fight mesothelioma, an aggressive asbestos-linked cancer with few effective treatments. A new experimental mesothelioma drug kills cancer cells by disabling PRX3, an antioxidant defense that tumors use to survive intense oxidative stress. In an early clinical trial, it controlled disease progression in 67% of patients and produced encouraging survival results, raising
WHO · 17 Oct 2024 · Research
Geneva 17 October 2024 – This afternoon, His Excellency Mr Jérôme Bonnafont, Permanent Representative of France to the United Nations in Geneva, and WHO Director-General Dr Tedros Adhanom Ghebreyesus met in the WHO headquarters for the signing of seven contribution agreements. The contribution totalling €24 million comes through the Ministry of Europe & Foreign Affairs. It fits in the France&n
NIH/NLM PubMed · 17 Apr 2026 · Research
PubMed's New & Noteworthy RSS feed provides another way to stay up to date with the latest news published in the NLM Technical Bulletin for PubMed. This RSS feed URL is changing, as the feed will now be generated directly from the Technical Bulletin, filtered for articles related to PubMed. If you are a current subscriber of the PubMed New & Noteworthy RSS feed, no action is necessary: the current URL will be redirec
Read at NIH/NLM PubMed →♡ Save
WHO · 10 Oct 2024 · Research
The World Health Organization (WHO) and the Kingdom of the Netherlands have renewed their strategic partnership in addressing the growing impacts of climate change on global health. The Netherlands is providing a new allocation of €500 000 for 2024 to WHO, reinforcing its commitment to climate resilience and sustainable healthcare systems worldwide. This allocation supports WHO’s ongoing efforts to strengt
WHO · 10 Apr 2025 · Research
On the occasion of the World Health Day 2025 dedicated to the theme of Healthier beginnings, hopeful futures, over 100 global WHO offices have organized wide-ranging public advocacy actions in collaboration with Member States, communities, health workers, partner and donor agencies and civil society organizations.
VitaLonga is an educational longevity resource, not a pharmacy, clinic, or doctor. Content is not medical advice and is not intended to diagnose, treat, cure, or prevent any disease (DSHEA). Supplements can interact with medications and are not appropriate in every pregnancy or health condition. Consult a licensed clinician, especially if you take medications, are pregnant or nursing, or have a diagnosed condition.
